IPSC vs PTC · rev $6.6M vs P/E 48, rev $2.74B
Century Therapeutics Inc (IPSC) versus PTC Inc (PTC) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
PTC Inc (PTC) is a software - application company listed on US.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
Latest reported PTC revenue for 2025-09-30 was $2.74B. Net income was $734.0M. Revenue was up 19.2% from 2024-09-30 to 2025-09-30. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
IPSC currently screens at market cap $47.8M. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
Not investment advice. Open the IPSC and PTC stock pages for the full models.
Not investment advice.